General Session
Friday, September 22nd

7:00 am

Registration / Continental Breakfast
The Westin Riverwalk, Navarro Ballroom

7:30 am Welcome and Introduction
Steven R. Bailey, MD and S. Hinan Ahmed, MD
SESSION I | Metabolomics and Atherosclerosis
Moderators: Robert J. Chilton, DO, James Furgerson, MD, Merry L. Lindsey, PhD, Juan A. Marmol-Velez, MD, Barbara S. Taylor, MD
7:40 am

Predictors of CV Event Using Risk Assessment Tools: How Can I Integrate These Into My Practice
Juan A. Marmol-Velez, MD

8:00 am

What Will Drive CV Therapy in the Next 10 Years: Genotype or Phenotype
Merry L. Lindsey, PhD

8:20 am

Novel Inflammatory Models of CAD; AIDS, Inflammation and Atherosclerosis
Barbara S. Taylor, MD

8:40 am Changing Landscape of CV Treatment in Type 2 Diabetes
Robert J. Chilton, DO

9:00 am Optimal Lipid Management in 2017; New Considerations in Cardiovascular Treatments
Robert J. Chilton, DO
9:20 am 

CT and CTA Imaging in the Early Risk Assessment of Atherosclerosis: Diagnosis and Prognosis
James Furgerson, MD

9:40 am Q & A
SESSION II | Optimizing Therapy for Heart Failure
Moderators: Ralph A. DeFronzo, MDTimothy D. Henry, MD, Rushit R. Kanakia, MD, James A. Watts, MD
10:00 am

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure
James A. Watts, MD

10:20 am

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition
Ralph A. DeFronzo, MD

10:40 am

Stem Cell Therapy Improves Outcomes in Severe Heart Failure: Hope or Hype
Timothy D. Henry, MD

11:00 am

HFrEF Versus HFpEF: Optimal Therapy for the Hospitalized Patient
Rushit R. Kanakia, MD

11:20 am

ARNI’s in Advanced Heart Failure: How Do They Work and When Should I Use Them?
James A. Watts, MD

11:40 am


11:45 am


12:00 pm

LUNCH / BREAKOUT SESSIONS | Select One Session to Attend 

1.  Navarro Ballroom - Percutaneous VAD, Destination VAD and Cardiac Transplant: What is the strategy in 2017?
Moderators: S. Hinan Ahmed, MD, Sonja Brune, RN, Chandra Kunavarapu, MD, James A. Watts, MD

2.  Zapata, Ballroom Level - Optimal Medical Therapy for ASHD Prevention in 2017: A Case Based Approach
Moderators: Robert J. Chilton, DO and Juan A. Marmol-Velez, MD


SESSION III | Advances in Echocardiography
Moderators: Steven R. Bailey, MD, John Gorcsan, III, MD, Rushit R. Kanakia, MD, Juan A. Marmol-Velez, MDMarielle Scherrer-Crosbie, MD, PhD 

1:00 pm

Diastolic Function: Noninvasive Assessment and Clinical Implications
Rushit R. Kanakia, MD

1:20 pm

Strain Imaging: The Role in 2017 and Beyond
John Gorcsan, III, MD

1:40 pm

The Guidelines: Current Recommendations for TAVR, Left Atrial Appendage Occlusion, and MitraClip
Steven R. Bailey, MD

2:00 pm

TAVR: Special Cases: Low-Gradient Aortic Stenosis
Juan A. Marmol-Velez, MD

2:20 pm

Multimodality Imaging Evaluation of Adult Patients During and After Cancer Therapy
Marielle Scherrer-Crosbie, MD, PhD

2:40 pm


SESSION IV | Update on Electrophysiology
Moderators: Rodney P. Horton, MD, Manoj M. Panday, MD, Jayasree Pillarisetti, MD
3:00 pm

Recent Advancements in Ablation Catheters and Mapping Systems; Look What We Can Do Now!
Rodney P. Horton, MD


Leadless Pacemaker Technology
Manoj M. Panday, MD

3:40 pm

Ablation Strategies and Techniques for VT/VF
Jayasree Pillarisetti, MD

4:00 pm

The Role of S-ICD Systems for Primary Prevention ICD Candidates
Rodney P. Horton, MD

4:20 pm

Recent Advancements in Cardiac Resynchronization Therapy
Manoj M. Panday, MD

4:40 pm Q&A
5:00 pm *Cool Cases Over Cold Cocktails - Supported by Abiomed
5:45 pm Closing Remarks